Categories: News

GT Molecular Launches Highly Sensitive Multiplexed PCR Tests for the Indian Coronavirus Variant

FORT COLLINS, Colo., May 19, 2021 /PRNewswire/ — GT Molecular, a company providing multiplexed, ultrasensitive PCR assays for wastewater-based epidemiology, cancer and pathogen panels for clinical labs, has started shipping its sensitive PCR tests to monitor the coronavirus variant, B.1.617. The virus was first spotted in India and upgraded to a global variant of concern by the WHO. It is sometimes referred to as the double mutant because it contains two mutations of concern and has been reported to be highly contagious and potentially capable of evading the immune system.

Two offerings are available:

  1. A national wastewater-based epidemiology testing service in which sewage from communities around the country is tested for the presence of the key mutations that define the B.1.617 double mutant variant from India.
  2. Ultrasensitive RT-PCR and dPCR reagent kits to empower academic, commercial, and public testing laboratories:
    1. Quantification and differentiation PCR kit for the B.1.617 variant
    2. Validated, quantitative standards and multiplex PCR assays for the original strain of Wuhan/WHO/4 (A), the UK variant (B.1.1.7), the South African variant (B.1.351), the Brazilian variant (P.1), the California variant (B.1.427) and the Indian variant (B.1.617).

These new offerings add to GT Molecular’s growing molecular assay catalog that includes SARS-CoV-2 multi-variant tests, cancer panels, multiplexed pathogen panels for clinical labs and quantitative standards.

About GT Molecular

GT Molecular is a leader in providing highly customizable, ultrasensitive digital PCR and qPCR tests.  GTM’s molecular app technology is an easy-to-use, end-to-end solution for rapid deployment and provides reliable and consistent measurements while detecting as little as 1-3 molecules of target nucleic acid.

ORDER & INFORMATION: info@gtmolecular.com,  970-498-1698

View original content:http://www.prnewswire.com/news-releases/gt-molecular-launches-highly-sensitive-multiplexed-pcr-tests-for-the-indian-coronavirus-variant-301295109.html

SOURCE GT Molecular

Staff

Recent Posts

cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting

Charlotte, North Carolina--(Newsfile Corp. - April 10, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

4 hours ago

Laboratory Services Cooperative Notifies Individuals of Security Incident

SEATTLE, April 10, 2025 /PRNewswire/ -- Laboratory Services Cooperative (LSC), a non-profit organization based in…

4 hours ago

True Dental Care Provides Notice of Data Incident

SUWANEE, Ga., April 10, 2025 /PRNewswire/ -- On February 3, 2025, True Dental Care ("True…

4 hours ago

Groundbreaking Study Explores THC Beverages as a Wellness Alternative to Alcohol

PHILADELPHIA, April 10, 2025 /PRNewswire/ -- MoreBetter, a leader in Real-World-Data collection and research, has…

4 hours ago

Launch and Learn: Media Invited to Science Webinar on NASA’s SpaceX CRS-32 Mission

Register today for the April 16 webinar, featuring cutting-edge biotech, plant biology, and airborne pollutant…

4 hours ago

Global Pharma Organization Implements Advanced Signals as Part of LifeSphere Safety Platform

BOSTON, April 10, 2025 /PRNewswire/ -- ArisGlobal, an innovative technology company at the forefront of life…

10 hours ago